Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Save for later
PPMI News
Donate Now
Parkinson's Research: PPMI Clinical Study Save for later

PPMI News

The Parkinson's Precision Medicine Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.

  • Samples in the lab.

    PPMI Dispatch: Early Signs of Disease and Striking Some Potential Markers

    Findings from the Parkinson’s Progression Markers Initiative show subtle symptoms in mutation carriers and that motor subtypes change with time and therapy.
    Learn more Save for later

  • Ask the PhD: Big Data, Better Answers

    In our latest Ask the PhD video, two MJFF staff scientists talk about why data matters in Parkinson’s.
    Learn more Save for later
  • 'Scientific American' Talks LRRK2 and Parkinson's Research with MJFF CEO Todd Sherer

    PPMI Dispatch: Findings and New Initiatives Shared at the Annual Meeting

    Investigators from the landmark Parkinson’s Progression Markers Initiative shared recent findings and initiatives to better define, measure and treat the disease.
    Learn more Save for later
  • PPMI Participant Hyam Kramer and his husband Tom posing in front of the Taj Mahal on their vacation.

    "Smart" Studies: Digital Health Tools Help Understand the Daily Parkinson's Experience

    Researchers are exploring how to utilize smartphones and smartwatches, and Parkinson's is a good test case.
    Learn more Save for later
  • PPMI Shows Protein Levels Lower in Spinal Fluid of People with Parkinson's

    PPMI Dispatch: Capturing the Parkinson's Experience Day to Day and Over Years

    The Parkinson's Progression Markers Initiative is gathering and analyzing data on the experience of Parkinson's to better define and measure the disease.
    Learn more Save for later
  • Close up of hand holding test tube

    Could an Antioxidant Protect LRRK2 Carriers from Parkinson's?

    A new study suggests urate may protect the genetic mutation that increases PD risk.
    Learn more Save for later
  • Testing Materials

    PPMI Dispatch: The Study Enters a New Phase

    The study completed enrollment and met the ambitious goal of enrolling 1,400 participants, including 600 with rare genetic mutations.
    Learn more Save for later
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.